Transcriptomic signatures have a place in short-term prediction of incident tuberculosis

Affiliations

¹ Center for Global Health AU, Department of Public Health, Aarhus University, Aarhus, Denmark; Bandim Health Project, INDEPTH network, Bissau, Guinea-Bissau. Electronic address: wejse@ph.au.dk.

Comment

Christian Wejse. Lancet Infect Dis. 2021 Mar.

. 2021 Mar;21(3):299-300.

doi: 10.1016/S1473-3099(20)30980-4. Epub 2021 Jan 25.

¹ Center for Global Health AU, Department of Public Health, Aarhus University, Aarhus, Denmark; Bandim Health Project, INDEPTH network, Bissau, Guinea-Bissau. Electronic address: wejse@ph.au.dk.

No abstract available

Comment on

Biomarker-guided tuberculosis preventive therapy (CORTIS): a randomised controlled trial.
Scriba TJ, Fiore-Gartland A, Penn-Nicholson A, Mulenga H, Kimbung Mbandi S, Borate B, Mendelsohn SC, Hadley K, Hikuam C, Kaskar M, Musvosvi M, Bilek N, Self S, Sumner T, White RG, Erasmus M, Jaxa L, Raphela R, Innes C, Brumskine W, Hiemstra A, Malherbe ST, Hassan-Moosa R, Tameris M, Walzl G, Naidoo K, Churchyard G, Hatherill M; CORTIS-01 Study Team. Scriba TJ, et al. Lancet Infect Dis. 2021 Mar;21(3):354-365. doi: 10.1016/S1473-3099(20)30914-2. Epub 2021 Jan 25. Lancet Infect Dis. 2021. PMID: 33508224 Free PMC article. Clinical Trial.